- RADIOHALOGEN PROSTHETIC MOIETIES AND RADIOLABELED BIOMOLECULES
-
The application is drawn to radiohalogen prosthetic moieties and precursors thereof and to radiolabeled biomolecules comprising such radiohalogen prosthetic moieties. The biomolecules have an affinity for particular types of cells and may specifically bind a certain cell, such as a cancer cell. Relevant biomolecules include antibodies, monoclonal antibodies, antibody fragments, peptides, other proteins, nanoparticles, aptamers, and pharamacological moieties used to target prostate-specific membrane antigen (PSMA).
- -
-
Page/Page column 23
(2021/05/21)
-
- HETEROCYCLIC INHIBITORS OF PCSK9
-
This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and formulations comprising such compounds, and methods of using and making such compounds. Compounds include compounds of Formula (I): (I) wherein A, D and Q are described herein.
- -
-
Page/Page column 100; 102
(2018/10/24)
-
- LOW MELTING NEMATIC DERIVATIVES OF PHENYL 3-METHYL-BENZOYLOXYBENZOATE.
-
A series of forty-eight low melting nematogenic dialkyl derivatives of type R**3 equals CH//3 (R**1 and R**2 are n-alkyls) are presented, one of which melts to the nematic phase at 43 C. The compounds were prepared by a six-step procedure with an average yield per step of 90%.
- Young,Green
-
-